{"id":385749,"date":"2023-07-18T00:00:00","date_gmt":"2023-07-18T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041106-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2024\/"},"modified":"2026-04-30T11:03:21","modified_gmt":"2026-04-30T11:03:21","slug":"47041106-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2024","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041106-medtech-hyaluronic-acid-viscosupplementation-market-insights-global-2024\/","title":{"rendered":"Hyaluronic Acid Viscosupplementation | Market Insights | Global | 2024"},"content":{"rendered":"<p>The\u00a0HA\u00a0viscosupplementation market was negatively impacted during the\u00a0COVID-19\u00a0pandemic due to the postponement of elective treatments. Nevertheless, with the easing of restrictions and the increase in vaccination rates, the market has\u00a0shown signs of recovery. Factors such as favorable demographics, increased patient awareness, improved physician training, effective marketing efforts by companies, and ongoing product innovation will contribute to the\u00a0modest\u00a0growth of the\u00a0HA\u00a0viscosupplementation market. Furthermore, premium-priced 1-injection products will continue to become\u00a0more popular\u00a0over the forecast period, whereas 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for\u00a0HA\u00a0viscosupplementation in the US, Europe, Asia Pacific, and Brazil from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-385749","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385749\/revisions"}],"predecessor-version":[{"id":387261,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385749\/revisions\/387261"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}